DHG Pharmaceutical JSC (HOSE:DHG)
Vietnam flag Vietnam · Delayed Price · Currency is VND
100,400
+100 (0.10%)
At close: Apr 10, 2026

DHG Pharmaceutical JSC Ratios and Metrics

Millions VND. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
13,126,90613,375,32313,584,51713,597,59111,100,34114,774,306
Market Cap Growth
0.20%-1.54%-0.10%22.50%-24.87%8.65%
Enterprise Value
10,973,01011,688,54611,903,27611,999,6998,991,68412,831,532
Last Close Price
100400.00102300.0098046.4888644.6570141.0590417.79
PE Ratio
15.9216.2218.0313.3711.6019.75
Forward PE
12.9613.4113.0810.9811.7017.65
PS Ratio
2.492.542.782.712.373.69
PB Ratio
3.173.233.322.802.593.90
P/TBV Ratio
3.313.383.472.912.714.12
P/FCF Ratio
11.1111.3211.05-16.6434.53
P/OCF Ratio
10.8211.0310.3156.6212.3232.65
PEG Ratio
-4.034.034.034.034.03
EV/Sales Ratio
2.082.222.442.391.923.21
EV/EBITDA Ratio
10.2510.9210.9210.527.7713.60
EV/EBIT Ratio
11.5212.2712.9311.408.3614.91
EV/FCF Ratio
9.289.899.69-13.4829.99
Debt / Equity Ratio
--0.160.120.030.06
Debt / EBITDA Ratio
--0.600.500.100.22
Debt / FCF Ratio
--0.53-0.170.49
Net Debt / Equity Ratio
-0.52-0.52-0.53-0.30-0.51-0.48
Net Debt / EBITDA Ratio
-2.01-2.01-1.98-1.30-1.89-1.92
Net Debt / FCF Ratio
-1.82-1.82-1.766.02-3.27-4.23
Asset Turnover
0.950.950.810.890.960.88
Inventory Turnover
2.582.582.071.922.082.19
Quick Ratio
2.922.921.912.253.283.18
Current Ratio
4.034.032.573.905.204.92
Return on Equity (ROE)
20.71%20.71%17.41%22.98%24.45%21.09%
Return on Assets (ROA)
10.70%10.70%9.53%11.66%13.74%11.87%
Return on Invested Capital (ROIC)
38.33%41.99%29.86%34.82%47.31%41.63%
Return on Capital Employed (ROCE)
22.60%22.60%22.10%21.40%24.70%22.30%
Earnings Yield
6.28%6.37%5.73%7.73%8.91%5.26%
FCF Yield
9.00%8.84%9.05%-1.81%6.01%2.90%
Dividend Yield
9.96%-10.20%8.46%4.99%3.87%
Payout Ratio
153.39%153.39%125.89%43.55%46.30%67.29%
Total Shareholder Return
9.96%-10.20%8.46%4.99%3.87%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.